在玻尿酸毒素的多尺度计算建模中,用于 glabellar 纹治疗的扩散:优化不同配方的注射量
Eqram Rahman1, Jean D A Carruthers2, Parinitha Rao3
1Research and Innovation Hub, Innovation Aesthetics, London, UK.
概括
将肉毒神经毒素A (BoNT/ A) 的注射量减少到0. 045毫升/ 位点,可增强目标局部化并最大限度地减少非目标效应. 较低的剂量提高了疗效,降低了免疫清除风险,挑战了当前的临床实践.
科学领域:
- 审美与再生医学
- 计算生物学和生物物理学
- 药理学和毒理学
背景情况:
- 肉毒神经毒素A (BoNT/A) 广泛用于纹,但结果因配方和扩散而有所不同.
- 目前的注射量建议缺乏机械基础,在敏感的解剖部位,如胸部,存在风险.
研究的目的:
- 为模拟BoNT/A扩散和有效性开发一个多尺度的in silico平台.
- 量化评估配方和注射量对BoNT/A传播和非目标效应的影响.
- 为优化BoNT/A注射量提供基于证据的建议.
主要方法:
- 集成的量子力学 (TD-DFT),分子动力学 (MD) 和有限元模型 (FEM) 的BoNT/A.
- 基于受体动力学和免疫反应的模型.
- 在各种注射体积中模拟了五种BoNT/A配方.
主要成果:
- 在BoNT/ A配方中,扩散特征和有效扩散 (Reff) 有显著差异.
- 将注射量从0. 025升至0. 1毫升显著增加了非目标效应和免疫清除风险.
- 最佳的制和有效性取决于配方,特定配方通常偏好较低的体积 (≤0. 045毫升).
结论:
- 将BoNT/A溶解体积降至≤0. 045毫升/部位,可增强目标局部化,并最大限度地减少不良影响.
- 稀释可以扩大扩散和免疫清除,这与一些临床启发学相矛盾.
- 这项研究为优化BoNT/A注射量提供了第一个量化证据.
相关概念视频
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
01:19One-Compartment Open Model for IV Bolus Administration: General Considerations
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant, half-life,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant, half-life,...
01:09One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution
The one-compartment open model is a simplified approach used in pharmacokinetics to understand the distribution and elimination of a drug administered through an intravenous bolus. This model assumes rapid drug dispersal throughout the body and elimination using a first-order process. Key pharmacokinetic parameters, such as the elimination rate constant (k), half-life (t1/2), and the apparent volume of distribution (Vd), can be estimated from this model. The elimination rate is calculated from...
00:56One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance
Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...